Background: Integrating hospital pharmacists into primary care settings can enhance the quality of patient care. However, the challenges vary across countries. China has piloted such collaborations between hospital pharmacists and primary care practitioners in recent years, but research on this subject is limited. This study aims to examine the integration of hospital pharmacists into primary care settings in Shenzhen, China, and identify the perceived barriers and facilitators.
Methods: From May 1 to November 30, 2022, a qualitative study gathered key informant interviews and on-site observations at three community health centers (CHCs) in Shenzhen. Two researchers collected the data, and all interviews were audio-recorded, transcribed verbatim, and analyzed using a thematic approach.
Results: Seventeen key informants were recruited (eight hospital pharmacists, six GPs, and three health administrators), most of whom were women (n = 11). Hospital pharmacists mainly conduct medication reviews and consultations in clinics or pharmacies of CHCs and engage in home visits with GPs in a few cases. Barriers to their integration include pharmacists' inadequate competency, a lack of patient recognition, GPs' resistance, and insufficient technological support. Patient needs, incentive systems, administrative leadership, social media use, and colocation were identified as facilitators of integration.
Conclusion: While unique opportunities may exist for primary care settings to improve patient care by integrating hospital pharmacists, it is essential to address the barriers stemming from individuals and the health system. Efforts should focus on the targeted training of pharmacists' practical skills, strategic campaigns to raise awareness among the public and healthcare providers, and policy-led efforts to foster technological progress.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11792204 | PMC |
http://dx.doi.org/10.1186/s12913-025-12351-2 | DOI Listing |
Can J Hosp Pharm
March 2025
, PhD, MSc, is a Project Coordinator with the Department of Pharmacy, The Children's Hospital of Eastern Ontario, Ottawa, Ontario.
Background: Climate change poses significant risks to both the environment and public health. The Canadian health care system accounts for an estimated 4.6% of national carbon emissions, and hospital pharmacy contributes substantially to these emissions.
View Article and Find Full Text PDFCan J Hosp Pharm
March 2025
, BSc(Pharm), MSc, MHA, is the Regional Medication Use Management Coordinator with Lower Mainland Pharmacy Services, Vancouver, British Columbia.
Background: Chloroprocaine has recently regained accessibility as a short-acting local anesthetic in Canada. It offers an alternative to bupivacaine, the predominant spinal anesthetic used at Vancouver Coastal Health sites in Vancouver, British Columbia.
Objective: To compare the recovery profile of surgical patients who received either chloroprocaine or bupivacaine for spinal anesthesia.
Int J Mol Sci
February 2025
Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-9510, Japan.
Patients with chronic cholestatic liver diseases often experience itch and struggle with this symptom. We discuss the mechanism of itch in patients with chronic cholestatic liver diseases, such as primary biliary cholangitis (PBC) and others, and their therapies, including ileal bile acid transporter (IBAT) inhibitors. In patients with PBC, there are high serum/plasma concentrations of multiple factors, including bile salts, bilirubin, endogenous opioids, lysophosphatidic acid (LPA), autotaxin, and histamine.
View Article and Find Full Text PDFJ Pharm Health Care Sci
March 2025
Division of Pharmacodynamics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-Ku, Tokyo, 105-8512, Japan.
Background: Population pharmacokinetic (PPK) models of vancomycin (VCM) commonly use creatinine clearance (CLcr) as a covariate for clearance (CL). However, relying on CLcr in patients of advanced age may lead to inaccuracies in estimating VCM clearance. Therefore, this study aimed to develop and validate a new PPK model specifically for patients aged 75 years and older.
View Article and Find Full Text PDFJ Pharm Health Care Sci
March 2025
Department of Cardiovascular Medicine, Tosei General Hospital, 160, Nishioiwake-cho, Seto, Aichi, 489-8642, Japan.
Background: Heart failure has a high readmission rate, but interventions by multiple professionals are effective. Although there is growing interest in the management of heart failure by community pharmacists in Japan, no effective method has been developed. We created and verified the effectiveness of a novel heart failure management protocol that community pharmacists could utilize.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!